Fusion event
HBV-FARP2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAG| |GTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGT
End
242401569/241462154 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/1006065; hsa-mir-3133/Downstream/15751;
Upstream sequence
CGGAAAACTGGGCCCGGGGTATGTTCCACGTCTGCATCAGGAAGTGCACCAGCAAGTCTGGCGCTCTGATGCAGGCACACTTAGAATGCGCACTGTTTGC
Downstream sequence
TCATTTTAATGACTTTTGTATGGGTTAGGTTTAATAATTTATAAGCACACACACACTCATGGACCTGTGTCTGCTAACCAGCTATGCCACTGGCAGTGAT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.